(RTTNews) - Medical technology company TELA Bio, Inc. (TELA) announced Monday that its Liora Monofilament Scaffold product was granted 510(k) clearance by the U.S. Food and Drug Administration.
Publicznie pokazujemy glowna mysl. Utworz darmowe konto, aby czytac caly artykul, zapisac go, omowic i polaczyc z kontekstem rynkowym oraz OSINT.